Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2026-01-02 @ 7:14 AM
Study NCT ID:
NCT03842267
Status:
COMPLETED
Last Update Posted:
2023-03-10
First Post:
2019-02-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Efficacy and Safety of Gemigliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Dapagliflozin and Metformin (SOLUTION Study)
Sponsor:
LG Chem
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05-13
Start Date Type:
ACTUAL
Primary Completion Date:
2021-05-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-30
Completion Date Type:
ACTUAL
First Submit Date:
2019-02-13
First Submit QC Date:
None
Study First Post Date:
2019-02-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-08
Last Update Post Date:
2023-03-10
Last Update Post Date Type:
ACTUAL